Press ReleasesSlipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology By globenewswire July 10, 2025 0 0 Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology Slipstream is proud to announce its co-authorship of a groundbreaking study on Hereditary Hemorrhagic Telangiectasia (HHT). Source: https://www.globenewswire.com/news-release/2025/07/10/3113613/0/en/Slipstream-Co-Authors-First-Comprehensive-Cost-Study-on-Hereditary-Hemorrhagic-Telangiectasia-in-the-American-Journal-of-Hematology.html Tagsco-authorshipcostjournalnewsreleasesourcestudy Previous articleADT To Release Second Quarter 2025 Results On Thursday, July 24, 2025Next articleNovartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS) globenewswire Aspen Wildfire Foundation Announces Donation of Type 3 Wildland Fire Engine July 11, 2025 AlphaGen Announces Closing of Debt Settlement Transaction July 11, 2025 Ripple partners with Bank of New York Mellon, XRP soars – LET Mining launches new cloud mining strategy for XRP holders July 11, 2025 WuXi AppTec Issues Positive Profit Alert for the First Half of 2025 July 11, 2025 South Bow Announces Timing of Second-quarter 2025 Results and Conference Call and Webcast July 11, 2025 Seeley Holdings Ltd. News Release July 11, 2025 Recent News WuXi AppTec Issues Positive Profit Alert for the First Half of 2025 Aspen Wildfire Foundation Announces Donation of Type 3 Wildland Fire Engine AlphaGen Announces Closing of Debt Settlement Transaction